NEW YORK, Jan. 29, 2019 /PRNewswire/ -- BBH Capital Partners ("BBHCP") announced today that it has completed the sale of its stake in portfolio company, KabaFusion Holdings LLC ("KabaFusion"), to a financial investor. Through a network of licensed pharmacies in seven states, KabaFusion is a provider of specialty pharmacy home infusion services to patients that have difficult-to-treat chronic and acute conditions including primary immune deficiency, neuromuscular and neurological conditions, and autoimmune disorders. BBHCP invested in KabaFusion in late 2014 and was the first outside investor in the company. Under the leadership of Dr. Sohail Masood, Founder and CEO, and the talented KabaFusion management team, the company nearly quadrupled its revenue over the past four years while maintaining its high standard of being an industry leader in clinical quality and patient care.
Bradley M. Langer, Managing Director at Brown Brothers Harriman & Co. ("BBH") and Co-Manager of BBHCP, commented, "We enjoyed working closely with KabaFusion over the past four years. Dr. Masood and KabaFusion's management team are highly experienced, proven executives in specialty home infusion and they have been fantastic partners. They have built a business of scale that continues to focus first and foremost on providing high-quality care to their patients. We greatly respect what the team has accomplished and look forward to watching them continue to grow their business in the coming years."
Dr. Masood added, "We couldn't be more pleased with our partnership with BBHCP. As a founder owned business, we were very careful in selecting our first equity partner. BBHCP has a focus on founder owned companies and is a longtime, experienced healthcare investor that had a true understanding of our business and industry. BBHCP spent considerable time working with our team to help accelerate revenue growth and improve margins." Houlihan Lokey's Healthcare Group served as the exclusive advisor to KabaFusion.
About BBH Capital Partners
BBHCP, a private equity strategy of BBH, provides friendly capital solutions to growth-oriented middle-market companies. Our flexible investment mandate gives us the ability to act as a control or non-control investor and to structure our investments as a combination of equity and subordinated debt securities as needed. BBHCP typically invests $30 - $125 million per platform investment, and our capital is used to support a variety of transactions, including management or leveraged buyouts, growth financings, recapitalizations (including dividend recapitalizations), buy-and-build strategies and acquisitions.
CONTACT: John Garretson, [email protected], 212-546-7819
SOURCE Brown Brothers Harriman